AMG 193, a Clinical Stage MTA-Cooperative PRMT5 Inhibitor, Drives Antitumor Activity Preclinically and in Patients with MTAP-Deleted Cancers
AMG 193 是一种临床阶段 MTA 协同 PRMT5 抑制剂,可在临床前和 MTAP 缺失癌症患者中发挥抗肿瘤活性
期刊:Cancer Discovery
影响因子:29.7
doi:10.1158/2159-8290.CD-24-0887
Brian Belmontes #, Katherine K Slemmons #, Chun Su, Siyuan Liu, Antonia N Policheni, Jodi Moriguchi, Hong Tan, Fang Xie, Daniel Andrew Aiello, Yajing Yang, Raul Lazaro, Famke Aeffner, Matthew G Rees, Melissa M Ronan, Jennifer A Roth, Mikkel Vestergaard, Sanne Cowland, Jan Andersson, Ian Sarvary, Qin